Synlogic Inc. named Andrew Gengos as its COO and head of corporate development.
Gengos was most recently the president and CEO of ImmunoCellular Therapeutics Ltd.
Discover more about S&P Global’s offerings
Synlogic names COO
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Synlogic Inc. named Andrew Gengos as its COO and head of corporate development.
Gengos was most recently the president and CEO of ImmunoCellular Therapeutics Ltd.